Metabolism Research from Bench to Bedside
Keynote:
Daniel Skovronsky, MD, PhD
CSO & EVP, Eli Lilly and Company
8:30 a.m. - 5:00 p.m.
NCRC, Dining Hall
Agenda
8:30 am – 9:00 am
Registration
9:00 am
Welcome & Opening Remarks
Marschall Runge, M.D., Ph.D.
9:05 am
Faculty Spotlights
To Be GIP or Not to Be GIP? That Is the Question
Randy Seeley, Ph.D.
Mechanisms of GLP-1 Receptor Agonist Action
Martin Myers, M.D., Ph.D.
Incretin Regulation of Hindbrain Neurons
Paula Goforth, Ph.D.
10:20 am
Morning Break
10:30 am
Keynote Introduction
Santa Ono, Ph.D.
Dr. Runge
10:35 am
Keynote Address
Harnessing Incretin Biology to Improve Human Health – Lilly’s Overnight Success, 100 Years in the Making
Daniel Skovronsky, M.D., Ph.D.
Chief Scientific Officer & Executive Vice President of Science and Technology, Eli Lilly and Company
President, Research Laboratories and Lilly Immunology
11:45 am
Panel Discussion
Therapeutic Challenges and Opportunities in Diabetes and Obesity
Moderator
Dr. Runge
Panelists
Daniel Skovronsky, M.D., Ph.D.
Mark Fendrick, M.D.
Carrie Ferrario, Ph.D.
Dina Hafez Griauzde, M.D.
Andrew Kraftson, M.D.
Randy Seeley, Ph.D.
12:30 pm
Lunch & Posters
1:45 pm
Afternoon Welcome
Karl Jepsen, Ph.D.
1:50 pm
Lightning Talks
Impact of the Incretin Mimetic Drug Tirzepatide on Obesity-Associated Breast Cancer Growth: Findings from a Preclinical Model
Amanda Kucinskas
Stressed Out: Glucose and Glipr1-Expressing Neurons as Keys to Uncovering the Neurocircuitry that Controls Stress-Induced Hyperglycemia
Jen Wloszek
Uncovering the Role of Hepatic FBW7 in Alcohol-Associated Liver Disease
Marina Bleiler, Ph.D.
LONP1 Regulation of Mitochondrial Protein Folding Provides Insight into Beta Cell Failure in Type 2 Diabetes
Jin Li, Ph.D.
RNA Binding Protein YTHDC1 Critically Regulates Liver Metabolism and Homeostasis
Qiantao Zheng, Ph.D.
2:25 pm
Afternoon Break
2:40 pm
Faculty Spotlights
Introduction
Dr. Myers
Incretin Mimetics in Primary Care: Promise and Pitfalls?
Lauren Oshman, M.D., M.P.H.
Advancements in Incretin Treatment in MODY
David Broome, M.D.
Expanding Equitable Access to Obesity Management
Mark Fendrick, M.D.
3:55 pm
Closing Remarks
Dr. Runge
4:00 pm
Reception & Posters